Proactive Investors: CytoDyn Inc. (OTCQB:CYDY) CEO Nader Pourhassan addresses the recent articles published by the Wall Street Journal and SeekingAlpha, in regards to its participation in Operation Warp Speed. Aug 26, 2020
Proactive Investors: CytoDyn updates on Type A meeting with FDA, gets nod from UK proceed with Phase 3 coronavirus trial Aug 20, 2020
Proactive Investors: CytoDyn submits Phase 2 mild-to-moderate coronavirus patient data to the FDA Aug 17, 2020
Proactive Investors: CytoDyn reveals latest mild-to-moderate coronavirus patient data in Phase 2 trial Aug 12, 2020
Proactive Investors: CytoDyn to submit request for pre-submission meetings in U.K. for Leronlimab Aug 7, 2020
